Vapotherm, Inc. (NYSE:VAPO – Get Rating) Director Anthony L. Arnerich purchased 20,000 shares of the business's stock in a transaction dated Tuesday, August 9th. The shares were acquired at an average cost of $1.65 per share, for a total transaction of $33,000.00. Following the acquisition, the director now owns 73,374 shares of the company's stock, valued at approximately $121,067.10. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website.

Vapotherm Stock Performance

Vapotherm stock opened at $1.80 on Friday. The company has a debt-to-equity ratio of 7.04, a quick ratio of 3.25 and a current ratio of 5.29. The firm has a market cap of $48.05 million, a price-to-earnings ratio of -0.49 and a beta of -0.22. Vapotherm, Inc. has a 1 year low of $1.62 and a 1 year high of $31.87. The firm's 50 day moving average price is $2.42 and its two-hundred day moving average price is $7.46.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on VAPO shares. Canaccord Genuity Group cut Vapotherm from a "buy" rating to a "hold" rating and cut their price target for the company from $12.00 to $5.00 in a report on Friday, May 6th. BTIG Research cut Vapotherm from a "buy" rating to a "neutral" rating in a report on Thursday, August 4th. William Blair cut Vapotherm from an "outperform" rating to a "market perform" rating in a report on Thursday, August 4th. Piper Sandler dropped their target price on Vapotherm from $2.50 to $2.00 and set an "underweight" rating on the stock in a report on Thursday, August 4th. Finally, Canaccord Genuity Group cut Vapotherm from a "buy" rating to a "hold" rating and dropped their target price for the stock from $12.00 to $5.00 in a report on Friday, May 6th. One research analyst has rated the stock with a sell rating and four have assigned a hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $4.75.

Hedge Funds Weigh In On Vapotherm

Vapotherm Company Profile

(Get Rating)

Vapotherm, Inc, a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface.

Further Reading

• Get a free copy of the StockNews.com research report on Vapotherm (VAPO)
• 2 Important Retail Stock Battles to Watch
• MarketBeat: Week in Review 8/8 – 8/12
• What Is WallStreetBets and What Stocks Are They Targeting?
• Institutions And Analysts Propel Jack In The Box Higher
• Can You Guess Which EV Stock Is Beating Tesla ?

Receive News & Ratings for Vapotherm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vapotherm and related companies with MarketBeat.com's FREE daily email newsletter.